Search results
Unlocking Intrinsic Value: Analysis of AbbVie Inc
GuruFocus.com via Yahoo Finance· 50 minutes agoIn this article, we will take a look into AbbVie Inc's (NYSE:ABBV) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value....
3 Magnificent Stocks That Are Passive Income Machines
Motley Fool via Yahoo Finance· 2 hours agoFind out why three Motley Fool contributors picked Eli Lilly (NYSE: LLY), AbbVie (NYSE: ABBV), and...
What Is the Dividend Payout for AbbVie Stock?
Motley Fool via Yahoo Finance· 22 hours agoMany investors hold a stake in AbbVie (NYSE: ABBV) because it offers exposure to the healthcare sector. Industry-based diversification, however, isn't...
AbbVie joins psychedelic push, inks $2B+ next-gen neuro deal with Gilgamesh
FierceBiotech· 15 hours agoAbbVie is wading into the waters of psychedelics, penning a pact with Gilgamesh Pharmaceuticals...
AbbVie widens search for next hit drug with psychiatric deal worth up to $2B
Crain s Chicago Business· 19 hours agoAbbVie, which already has a growing psychiatry portfolio, is paying Gilgamesh $65 million upfront and as much as $1.95 billion in aggregate option fees and milestones in the ...
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to...
Hometownsource.com· 1 day ago- Collaboration to leverage AbbVie's psychiatry expertise and Gilgamesh's innovative research platform to develop next-generation neuroplastogens for the treatment of psychiatric disorders
AbbVie Inc. (NYSE:ABBV) Receives $174.31 Average Target Price from Brokerages
ETF DAILY NEWS· 2 days agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the thirteen research firms that are presently covering ...
AbbVie Stock Poised for New All-Time Highs in 2024 | Investing.com
Investing.com· 6 days agoAbbVie had a better-than-expected quarter and guided higher; the post-release price drop is a dip...
(ABBV) - Analyzing AbbVie's Short Interest - AbbVie (NYSE:ABBV)
Benzinga· 4 days agoAbbVie's ABBV short percent of float has risen 4.05% since its last report. Based on its trading volume, it would take traders 2.43 days to cover their short positions on ...
3 Rock-Solid Dividend Stocks That Are Ideal for Retirees
Motley Fool via Yahoo Finance· 4 days agoThree stocks that you'll want to consider for your portfolio if you're a retiree craving some...
